Waters Corp (WAT)

NYSE:WAT

WAT

Waters

RESEARCH TOOLSreports

Want to see WAT full AI Analyst Report?

Waters (WAT) Stock Forecast & Price Target

443 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

WAT Analyst Ratings

Moderate Buy

7 Buy

8 Hold

0 Sell

Based on 15 analysts giving stock ratings to

Waters

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

WAT Stock 12 Month Forecast

Average Price Target

$375.59

▲(14.59% Upside)

Based on 15 Wall Street analysts offering 12 month price targets for Waters in the last 3 months. The average price target is $375.59 with a high forecast of $440.00 and a low forecast of $301.88. The average price target represents a 14.59% change from the last price of $327.77.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"289":"$289","327":"$327","365":"$365","403":"$403","441":"$441"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":440,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$440.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":375.592,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$375.59</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":301.88,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$301.88</span>\n  </div></div>","useHTML":true}}],"tickPositions":[289,327,365,403,441],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,307.12,317.34153846153845,327.56307692307695,337.7846153846154,348.00615384615384,358.22769230769234,368.4492307692308,378.6707692307692,388.89230769230767,399.11384615384617,409.3353846153846,419.5569230769231,429.77846153846156,{"y":440,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,307.12,312.3870769230769,317.65415384615386,322.92123076923076,328.1883076923077,333.4553846153846,338.7224615384615,343.9895384615385,349.2566153846154,354.5236923076923,359.79076923076923,365.0578461538461,370.3249230769231,{"y":375.592,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,307.12,306.7169230769231,306.31384615384616,305.91076923076923,305.5076923076923,305.1046153846154,304.70153846153846,304.29846153846154,303.8953846153846,303.4923076923077,303.08923076923077,302.68615384615384,302.2830769230769,{"y":301.88,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":341.83,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":343.68,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":357.04,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":290.31,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":296.48,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":319.81,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":349.6,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":397.79,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":379.83,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":379.31,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":307.23,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":299.89,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":307.12,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$440.00

Average Price Target$375.59

Lowest Price Target$301.88

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Daniel Arias

Stifel Nicolaus

$380

Hold

15.93%

Upside

Reiterated

05/18/26

Stifel Nicolaus Sticks to Its Hold Rating for Waters (WAT)

Brandon Couillard

Wells Fargo

$355→$370

Hold

12.88%

Upside

Reiterated

05/14/26

Analysts Offer Insights on Healthcare Companies: vTv Therapeutics (NASDAQ: VTVT), Waters (NYSE: WAT) and Alpha Teknova (NASDAQ: TKNO)

Subbu Nambi

Guggenheim

$440

Buy

34.24%

Upside

Reiterated

05/11/26

Analysts Offer Insights on Healthcare Companies: DocGo (NASDAQ: DCGO), Arcturus Therapeutics (NASDAQ: ARCT) and Waters (NYSE: WAT)

Justin Bowers

Deutsche Bank

$330→$350

Hold

6.78%

Upside

Reiterated

05/07/26

Waters price target raised to $350 from $330 at Deutsche BankWaters price target raised to $350 from $330 at Deutsche Bank

Luke Sergott

Barclays

$400→$425

Buy

29.66%

Upside

Reiterated

05/07/26

Barclays Sticks to Their Buy Rating for Waters (WAT)

Daniel Brennan

TD Cowen

$345→$385

Hold

17.46%

Upside

Assigned

05/06/26

Daniel Brennan Lifts Waters Price Target to $385 but Maintains Hold on Balanced Risk‑Reward and BD Uncertainty

Catherine Ramsey Schulte

Robert W. Baird

$362→$387

Buy

18.07%

Upside

Reiterated

05/06/26

Waters price target raised to $387 from $362 at BairdWaters price target raised to $387 from $362 at Baird

Lu Li

UBS

$330→$375

Hold

14.41%

Upside

Reiterated

05/06/26

Waters price target raised to $375 from $330 at UBSWaters price target raised to $375 from $330 at UBS

Evie Koslosky

Goldman Sachs

$375→$380

Buy

15.93%

Upside

Reiterated

05/06/26

Waters (WAT) Receives a Buy from Goldman Sachs

Casey Woodring

J.P. Morgan

$330→$345

Hold

5.26%

Upside

Assigned

05/06/26

Waters price target raised to $345 from $330 at JPMorganWaters price target raised to $345 from $330 at JPMorgan

Michael Ryskin

Bank of America Securities

$350→$370

Hold

12.88%

Upside

Reiterated

05/05/26

Analysts Conflicted on These Healthcare Names: Jazz Pharmaceuticals (NASDAQ: JAZZ), Dianthus Therapeutics (NASDAQ: DNTH) and Waters (NYSE: WAT)

Vijay Kumar

Evercore ISI

$350

Buy

6.78%

Upside

Reiterated

05/05/26

Waters (WAT) Receives a Buy from Evercore ISI

Kallum Titchmarsh

Morgan Stanley

$350

Hold

6.78%

Upside

Reiterated

05/05/26

Equal-Weight Maintained on Waters as Integration Progresses; Price Target Reaffirmed at $350

Matt Larew

William Blair

$301.88

Buy

-7.90%

Downside

Reiterated

05/05/26

Analyst Reiterates Buy on Waters as Pharma Demand, BD Synergies and Earnings Outlook Drive Positive Risk-Reward

Patrick B Donnelly

Citi

$425

Buy

29.66%

Upside

Assigned

04/07/26

Citi Sticks to Its Buy Rating for Waters (WAT)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Daniel Arias

Stifel Nicolaus

$380

Hold

15.93%

Upside

Reiterated

05/18/26

Stifel Nicolaus Sticks to Its Hold Rating for Waters (WAT)

Brandon Couillard

Wells Fargo

$355→$370

Hold

12.88%

Upside

Reiterated

05/14/26

Analysts Offer Insights on Healthcare Companies: vTv Therapeutics (NASDAQ: VTVT), Waters (NYSE: WAT) and Alpha Teknova (NASDAQ: TKNO)

Subbu Nambi

Guggenheim

$440

Buy

34.24%

Upside

Reiterated

05/11/26

Analysts Offer Insights on Healthcare Companies: DocGo (NASDAQ: DCGO), Arcturus Therapeutics (NASDAQ: ARCT) and Waters (NYSE: WAT)

Justin Bowers

Deutsche Bank

$330→$350

Hold

6.78%

Upside

Reiterated

05/07/26

Waters price target raised to $350 from $330 at Deutsche BankWaters price target raised to $350 from $330 at Deutsche Bank

Luke Sergott

Barclays

$400→$425

Buy

29.66%

Upside

Reiterated

05/07/26

Barclays Sticks to Their Buy Rating for Waters (WAT)

Daniel Brennan

TD Cowen

$345→$385

Hold

17.46%

Upside

Assigned

05/06/26

Daniel Brennan Lifts Waters Price Target to $385 but Maintains Hold on Balanced Risk‑Reward and BD Uncertainty

Catherine Ramsey Schulte

Robert W. Baird

$362→$387

Buy

18.07%

Upside

Reiterated

05/06/26

Waters price target raised to $387 from $362 at BairdWaters price target raised to $387 from $362 at Baird

Lu Li

UBS

$330→$375

Hold

14.41%

Upside

Reiterated

05/06/26

Waters price target raised to $375 from $330 at UBSWaters price target raised to $375 from $330 at UBS

Evie Koslosky

Goldman Sachs

$375→$380

Buy

15.93%

Upside

Reiterated

05/06/26

Waters (WAT) Receives a Buy from Goldman Sachs

Casey Woodring

J.P. Morgan

$330→$345

Hold

5.26%

Upside

Assigned

05/06/26

Waters price target raised to $345 from $330 at JPMorganWaters price target raised to $345 from $330 at JPMorgan

Michael Ryskin

Bank of America Securities

$350→$370

Hold

12.88%

Upside

Reiterated

05/05/26

Analysts Conflicted on These Healthcare Names: Jazz Pharmaceuticals (NASDAQ: JAZZ), Dianthus Therapeutics (NASDAQ: DNTH) and Waters (NYSE: WAT)

Vijay Kumar

Evercore ISI

$350

Buy

6.78%

Upside

Reiterated

05/05/26

Waters (WAT) Receives a Buy from Evercore ISI

Kallum Titchmarsh

Morgan Stanley

$350

Hold

6.78%

Upside

Reiterated

05/05/26

Equal-Weight Maintained on Waters as Integration Progresses; Price Target Reaffirmed at $350

Matt Larew

William Blair

$301.88

Buy

-7.90%

Downside

Reiterated

05/05/26

Analyst Reiterates Buy on Waters as Pharma Demand, BD Synergies and Earnings Outlook Drive Positive Risk-Reward

Patrick B Donnelly

Citi

$425

Buy

29.66%

Upside

Assigned

04/07/26

Citi Sticks to Its Buy Rating for Waters (WAT)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

TRAXFirst Tracks Biotherapeutics Inc

EVMNEvommune, Inc.

MPLTMapLight Therapeutics, Inc.

MAZEMaze Therapeutics, Inc.

AAPGAscentage Pharma Group International Unsponsored ADR

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Waters

3 Months

Catherine Ramsey SchulteRobert W. Baird

Success Rate

10/15 ratings generated profit

Average Return

+4.33%

Copying Catherine Ramsey Schulte's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +4.33% per trade.

1 Year

Catherine Ramsey SchulteRobert W. Baird

Success Rate

11/15 ratings generated profit

Average Return

+8.01%

Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 73.33% of your transactions generating a profit, with an average return of +8.01% per trade.

2 Years

Catherine Ramsey SchulteRobert W. Baird

Success Rate

11/15 ratings generated profit

Average Return

+12.01%

Copying Catherine Ramsey Schulte's trades and holding each position for 2 Years would result in 73.33% of your transactions generating a profit, with an average return of +12.01% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

WAT Analyst Recommendation Trends

Rating

Jan 26

Feb 26

Mar 26

Apr 26

May 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, WAT has received 11 Buy Ratings, 13 Hold Ratings, and 0 Sell Ratings. WAT average Analyst price target in the past 3 months is 375.59.

Each month's total comprises the sum of three months' worth of ratings.

WAT Financial Forecast

WAT Earnings Forecast

Next quarter’s earnings estimate for WAT is $3.01 with a range of $2.98 to $3.05. The previous quarter’s EPS was $2.70. WAT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year WAT has Performed in-line its overall industry.

WAT Sales Forecast

Next quarter’s sales forecast for WAT is $1.62B with a range of $1.60B to $1.63B. The previous quarter’s sales results were $1.27B. WAT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year WAT has Performed in-line its overall industry.

WAT Stock Forecast FAQ

What is WAT’s average 12-month price target, according to analysts?

Based on analyst ratings, Waters Corp’s 12-month average price target is 375.59.

What is WAT’s upside potential, based on the analysts’ average price target?

Waters Corp has 14.59% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is WAT a Buy, Sell or Hold?

Waters Corp has a consensus rating of Moderate Buy which is based on 7 buy ratings, 8 hold ratings and 0 sell ratings.

What is Waters Corp’s price target?

The average price target for Waters Corp is 375.59. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $440.00 ,the lowest forecast is $301.88. The average price target represents 14.59% Increase from the current price of $327.77.

What do analysts say about Waters Corp?

Waters Corp’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.

How can I buy shares of WAT?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Waters (WAT) Stock Forecast & Price Target

WAT Analyst Ratings

WAT Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Waters

WAT Analyst Recommendation Trends

WAT Financial Forecast

WAT Earnings Forecast

WAT Sales Forecast

WAT Stock Forecast FAQ

Detailed List of Analyst Forecasts